Testi di riferimento
Antonelli, Guido, et al. (a cura di), Principi di microbiologia medica, C.E.A., Rozzano 20122.
Grignolio, Andrea, Chi ha paura dei vaccini?, Codice, Torino 2016.
Kasper, Dennis L., et al. (ed. by), Harrison’s principles of internal medicine, McGraw-Hill, New York 201519.
Knipe, David M. – Howley, Peter M. (ed. by), Fields Virology, Wolters Kluver / Lippincott Williams and Wilkins, Philadelphia 20136.
Mantovani, Alberto (con Florianello, Monica), Immunità e vaccini. Perché è giusto proteggere la nostra salute e quella dei nostri figli, Mondadori, Milano 2016.
Oldstone, Michael B.A., Viruses, Plagues, and History, Oxford University Press, New York 1998.
Plotkin, Stanley A. – Orenstein, Walter – Offit, Paul A. (ed. by), Vaccines, Saunders, Philadelphia 20126.
Saluzzo, Jean-François, La guerre contre les virus, Plon, Paris 2002.
Studi e ricerche
Adegbola, Richard A., et al., Elimination of “Haemophilus influenzae” type b (HIB) disease from the Gambia after the introduction of routine immunisation with a HIB conjugate vaccine: a prospective study, in “The Lancet”, 366, 9480, 2005, pp. 144-50.
Behbehani, Abbas M., The smallpox story: life and death of an old disease, in “Microbiological Reviews”, 4, 47, 1983, pp. 455-509.
Beltrami, Elise M., et al., Risk and management of blood-borne infections in health care workers, in “Clinical Microbiology Reviews”, 3, 13, 2000, pp. 385-407.
Berg, Jolice P. van den, Transplacental transport of IgG antibodies to preterm infants: a review of the literature, in “Early Human Development”, 2, 87, 2011, pp. 67-72.
Bohlke, Kari, et al., Risk of anaphylaxis after vaccination of children and adolescents, in “Pediatrics”, 4, 112, 2003, pp. 815-20.
Bonanni, Paolo – Boccalini, Sara – Bechini, Angela, Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence, in “Vaccine”, suppl. 1, 27, 2009, pp. A46-A53.
Brown, Natasha – Berkovic, Samuel – Scheffer, Ingrid, Vaccination, seizures and “vaccine damage”, in “Current Opinion in Neurology”, 2, 20, 2007, pp. 181-87.
Centers for Disease Control and Prevention (CDC), Diphtheria, in Epidemiology and prevention of vaccine-preventable diseases (The Pink Book, 13th edition), Public Health Foundation, Washington D.C. 2015, pp. 107-18.
—, Elimination of rubella and congenital rubella syndrome – United States, 1969-2004, in “Morbidity and Mortality Weekly Report (MMWR)”, 11, 54, 2005, pp. 279-82.
—, “Haemophilus influenzae” type b, in Epidemiology and prevention of vaccine-preventable diseases (The Pink Book, 13th edition), Public Health Foundation, Washington D.C. 2015, pp. 119-33.
—, Hepatitis B, in Epidemiology and prevention of vaccine-preventable diseases (The Pink Book, 13th edition), Public Health Foundation, Washington D.C. 2015, pp. 149-73.
—, Invasive “Haemophilus influenzae” type b disease in five young children – Minnesota, 2008, in “Morbidity and Mortality Weekly Report (MMWR)”, 3, 58, 2009, pp. 58-60.
—, Poliomyelitis, in Epidemiology and prevention of vaccine-preventable diseases (The Pink Book, 13th edition), Public Health Foundation, Washington D.C. 2015, pp. 297-310.
—, Progress toward elimination of “Haemophilus influenzae” type b invasive disease among infants and children – United States, 1998-2000, in “Morbidity and Mortality Weekly Report (MMWR)”, 11, 51, 2002, pp. 234-37.
—, Reported cases and deaths from vaccine preventable diseases, United States, 1950-2013, in Epidemiology and prevention of vaccine-preventable diseases (The Pink Book, 13th edition), Public Health Foundation, Washington D.C. 2015, Appendix E 1-2.
Chen, Ding-Shinn, Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B, in “Journal of Hepatology”, 4, 50, 2009, pp. 805-16.
Chiang, Chun-Ju, et al., Thirty-year outcomes of the national hepatitis B immunization program in Taiwan, in “The Journal of American Medical Association”, 9, 310, 2013, pp. 974-76.
Chien, Yin-Chu, et al., Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched, in “Epidemiologic Reviews”, 1, 28, 2006, pp. 126-35.
Ciofi Degli Atti, Marta Luisa, et al., Rubella control in Italy, in “Eurosurveillance”, 4, 9, 2004, pp. 17-18.
“Communicable disease threats report”, ECDC, 13-19 marzo 2016.
Conyn van Spaendonck, Marina A.E., et al., Circulation of poliovirus during the poliomyelitis outbreak in the Netherlands in 1992-1993, in “American Journal of Epidemiology”, 9, 143, 1996, pp. 929-35.
Cummings, Teresa, et al., Reduction of HPV infections through vaccination among at-risk urban adolescents, in “Vaccine”, 37, 30, 2012, pp. 5496-499.
Davis, Niall F., et al., The increasing incidence of mumps orchitis: a comprehensive review, in “BJU International”, 8, 105, 2010, pp. 1060-1065.
Drolet, Mélanie, et al., Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis, in “The Lancet Infectious Diseases”, 5, 15, 2015, pp. 565-80.
Duintjer Tebbens, Radbound J., et al., Expert review on poliovirus immunity and transmission, in “Risk Analysis”, 4, 33, 2013, pp. 544-605.
Eichner, Martin – Brockmann, Stefan, Polio emergence in Syria and Israel endangers Europe, in “The Lancet”, 382, 9907, 2013, p. 1777.
Fine, Paul – Eames, Ken – Heymann, David L., ‘‘Herd immunity’’: a rough guide, in “Clinical Infectious Diseases”, 7, 52, 2011, pp. 911-16.
Furck, Anke K. – Richter, Jost Wigand – Kattner, Evelyn, Very low birth weight infants have only few adverse events after timely immunization, in “Journal of Perinatology”, 2, 30, 2009, pp. 118-21.
Galea, Susan A., et al., The safety profile of varicella vaccine: a 10-year review, in “The Journal of Infectious Diseases”, suppl. 2, 197, 2008, pp. S165-S169.
Garland, Suzanne M., et al., Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases, in “The New England Journal of Medicine”, 356, 2007, pp. 1928-943.
Garon, Julie R. – Cochi, Stephen L. – Orenstein, Walter A., The challenge of global poliomyelitis eradication, in “Infectious Disease Clinics”, 4, 29, 2015, pp. 651-65.
General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP), in “Morbidity and Mortality Weekly Report (MMWR)”, RR-2, 51, 2002, pp. 1-36.
Gerber, Jeffrey S. – Offit, Paul A., Vaccines and autism: a tale of shifting hypotheses, in “Clinical Infectious Diseases”, 4, 48, 2009, pp. 456-61.
Greenwood, Kathryn P., et al., A systematic review of human-to-human transmission of measles vaccine virus, in “Vaccine”, 23, 34, 2016, pp. 2531-536.
Hahné, Susan, et al., Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada, in “The Pediatric Infectious Disease Journal”, 9, 28, 2009, pp. 795-800.
Hambidge, Simon J., et al., Timely versus delayed early childhood vaccination and seizures, in “Pediatrics”, 6, 133, 2014, pp. 1492-499.
HogenEsch, Harm, Mechanism of immunopotentiation and safety of aluminum adjuvants, in “Frontiers in Immunology”, 3, 2013, art. 406.
Honda, Hideo – Shimizu, Yasuo – Rutter, Michael, No effect of MMR withdrawal on the incidence of autism: a total population study, in “Journal of Child Psychology and Psychiatry”, 6, 46...